SARS-CoV-2 Vaccine (Vero cell), Inactivated (Beijing Minhai Biological)

新型冠状病毒灭活疫苗 (Vero细胞) (北京民海生物)

Report date: 2025/01/07 11:28:57

Base Information

Drug NameSARS-CoV-2 Vaccine (Vero cell), Inactivated (Beijing Minhai Biological)
Drug Alias NameMinhai COVID-19 vaccine康泰民海新冠疫苗Inactivated SARS-CoV-2 vaccineKCONVAC可维克
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaCoronavirus Disease 2019 (COVID-19)
Original Approved Country/TerritoryMainland China
Original Approved Date2021/05/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYong Tai BerhadSinergium Biotech SAShenzhen Kangtai Biological Products Co Ltd
Inactive CompaniesBeijing Minhai Biotechnology Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia